June 3, 2024
Project Bulletin: June 3, 2024
In a move to further increase manufacturing capacity for its active pharmaceutical ingredients (API) used to treat chronic diseases, Eli Lilly has announced a $5.3 billion boost to its Lebanon, Indiana, facility investment.